Back
PTC Therapeutics Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
43
PTCT
PTC Therapeutics
Last Price:
43.15
Seasonality Move:
30.95%
Buy
68
CRNX
Crinetics Pharmaceuticals
Last Price:
59.10
Seasonality Move:
10.45%
Sell
43
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $40.87. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
- The current Crinetics Pharmaceuticals [CRNX] share price is $57.81. The Score for CRNX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CRNX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $40.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $57.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 57.23 | Buy |
| Chaikin Money Flow: | 222852 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.87 - 41.23) | Buy |
| Bollinger Bands (100): | (32.01 - 38.07) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 59.55 | Buy |
| Chaikin Money Flow: | 308844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.77 - 58.39) | Buy |
| Bollinger Bands (100): | (47.89 - 55.75) | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.76 | Buy |
| 20-day SMA: | 39.92 | Buy |
| 50-day SMA: | 36.88 | Buy |
| 200-day SMA: | 32.51 | Buy |
| 8-day EMA: | 40.55 | Buy |
| 20-day EMA: | 39.64 | Buy |
| 50-day EMA: | 37.6 | Buy |
| 200-day EMA: | 34.14 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.8 | Buy |
| 20-day SMA: | 56.29 | Buy |
| 50-day SMA: | 53.83 | Buy |
| 200-day SMA: | 47.57 | Buy |
| 8-day EMA: | 56.99 | Buy |
| 20-day EMA: | 56.2 | Buy |
| 50-day EMA: | 54.33 | Buy |
| 200-day EMA: | 47.18 | Buy |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.74 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
PTC Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||